DOES 90-DAY PRESCRIPTION SUPPLY AT RETAIL IMPROVE COMPLIANCE IN A MANAGED CARE SETTING?
Author(s)
Patrick Thiebaud, PhD, Economist1, Bimal V. Patel, PharmD/MS, Director OR21Medimpact Healthcare Systems, Inc, San Diego, CA, USA; 2 MedImpact Healthcare Systems, Inc, San Diego, CA, USA
OBJECTIVE: To evaluate the effect of a new program that allowed patients to fill 90-day prescriptions in retail pharmacies. METHODS: The research is a case-control natural experiment. A total of 38,852 patients in the treatment cohort received drug benefit through a managed care organization that initiated a 90-day supply retail option in January 1, 2005. Patients were evaluated if they used agents to treat diabetes, dyslipidemia, or hypertension and were continuously eligible for benefit for 18 months – 9 months pre- and post- January 1, 2005. The control cohort comprised 49,738 patients who were insured in the same managed care organization, and used the same drugs and were followed for the same length of time the year before and after January 1, 2004. Treatment and control patients were matched on a number of dimensions - including demographic characteristics, copays, and baseline drug consumption - using the weighted sum of absolute case-control differences. The effect of the new 90-day retail program was then evaluated with the matched sample using the difference-in-differences estimator. Two outcomes were evaluated: the number of prescription in the above therapeutic classes and the duration of supply. RESULTS: The introduction of 90-day dispensing at retail allowed patients to reduce the number of prescription they filled by an average of 1.2 for diabetes, 2.2 for antilipidemics, and 4.0 for antihypertensives. Despite this reduction, actual total drug supply increased as the average length of supply per prescription increased. Total supply increased by 4.3 days for antihypertensives, 11.5 days for antilipidemics, and by 75.3 days for diabetes. CONCLUSION: Reactions to the introduction of a new retail dispensing option demonstrate that dispensing flexibility is valuable to the patients and can lead to improvement in compliance, presumably because refilling a prescription every 30 days can be burdensome.
Conference/Value in Health Info
2006-05, ISPOR 2006, Philadelphia, PA
Value in Health, Vol. 9, No.3 (May/June 2006)
Code
PCV57
Topic
Patient-Centered Research
Topic Subcategory
Adherence, Persistence, & Compliance
Disease
Cardiovascular Disorders, Diabetes/Endocrine/Metabolic Disorders